Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Sunitinib in Bronchoalveolar Carcinoma or Never-Smokers With Any Lung Adenocarcinoma

NCT00430261 is registered in ClinicalTrials.gov with Swedish Medical Center as lead sponsor.

NCT NCT00430261
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00430261 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Sunitinib in Bronchoalveolar Carcinoma or Never-Smokers With Any Lung Adenocarcinoma
Lead sponsor
Swedish Medical Center
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2007
Completion date
October 31, 2010
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma, lung cancer